Skip to main content
. 2019 Jul 24;24(15):2686. doi: 10.3390/molecules24152686

Figure 4.

Figure 4

Effect of Wiskostatin and compounds 10, 14, and 15 on actin cytoskeleton of metastatic cancer cell MDA-MB-231. MDA-MB-231 metastatic breast cancer cells were treated with vehicle or Wiskostatin (2 µM) and compounds 10, 14, or 15 at 10 µM for 24 h to determine changes in actin cytoskeletal structures. Cells were fixed, permeabilized, and stained with rhodamine phalloidin to visualize F-actin. Arrows, lamellipodia; arrowheads, filopodia.